Using a digital tool to prevent cardiovascular diseases and type 2 diabetes

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study involves participants being randomized to either use a digital lifestyle tool for three years or to a control group without access to the tool. The aim is to evaluate the long-term efficacy of this web-based tool in promoting sustainable lifestyle changes that could prevent cardiovascular diseases and type 2 diabetes. The study will track the incidence and development of these conditions through clinical registries, providing insights into the effectiveness of continuous digital support compared to traditional methods. The research addresses the need for innovative and scalable lifestyle interventions in healthcare.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* informed consent
* Age above 35 years

Exclusion Criteria:

* type 1 diabetes, MODY or secondary diabetes
* conditions or treatments that in the judgement of the Investigator could affect the study evaluation
* connection with the study team, funders, authorities, universities or other public or private bodies in such a way that specific interests in the study outcomes could be suspected.

Where it's running

• Skane University Hospital
  Malmö, Sweden Recruiting

Study contacts

• Principal investigator: Anders Rosengren — Göteborg University
• Study coordinator: Birgitta Abrahamsson
• Email: birgitta.x.abrahamsson@skane.se
• Phone: 0705316704

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Comparing advice on moderate drinking versus abstention for health outcomes

  This study is testing whether giving advice on moderate drinking or complete abstention is better for the health of adults over 50 in Spain.

  Recruiting Clinica Universidad de Navarra, Universidad de Navarra · Pamplona, Navarre · NCT06338215

• Screening and treatment for heart disease in patients with type 2 diabetes

  This study tests if screening for heart disease and adjusting treatment can help people with type 2 diabetes who don’t have heart problems feel better and stay healthier.

  Recruiting Phase 4 University of Aarhus · Odense · NCT05700877

• Examining gut microbiota changes in patients undergoing metabolic surgery

  This study is testing how metabolic surgery affects gut bacteria and heart health in patients, especially focusing on the African American community, over the next 10 years.

  Recruiting Vanderbilt University Medical Center · Nashville, Tennessee · NCT05000996

• A registry for studying Non-Alcoholic Fatty Liver Disease in Europe

  This study is collecting health information and samples from people with Non-Alcoholic Fatty Liver Disease to learn more about the disease and find better ways to track its progress.

  Recruiting at 33 sites Newcastle University · Antwerp and 36 other locations · NCT04442334

• Acute Blood Flow Restriction Walking in Type 2 Diabetes

  This study tests whether adding blood flow restriction to treadmill walking affects immune cells in adults with type 2 diabetes.

  Recruiting University of British Columbia · Kelowna, British Columbia · NCT07928531

• Continuous Glucose Monitoring in Type 2 Diabetes Not on Insulin

  This study tests whether using a continuous glucose monitoring system helps people with type 2 diabetes who aren’t using insulin to improve blood sugar control and quality of life.

  Recruiting Medical University of Bialystok · Bialystok · NCT07919236

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.